The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Sep. 24, 2014
Applicant:
Universität Zu Köln, Cologne, DE;
Inventors:
Albrecht Berkessel, Erftstadt, DE;
Mark Krüger, Hürth, DE;
Karl-Anton Kreuzer, Bonn, DE;
Simon Poll-Wolbeck, Cologne, DE;
Assignee:
UNIVERSITÄT ZU KOLN, Cologne, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 203/04 (2006.01); C07F 7/18 (2006.01); C07C 309/76 (2006.01); C07C 247/10 (2006.01); C07C 69/78 (2006.01); C07C 69/76 (2006.01); A61K 31/621 (2006.01); C07C 69/86 (2006.01); C07C 69/75 (2006.01); A61K 31/215 (2006.01); A61K 31/24 (2006.01); A61K 31/235 (2006.01); C07F 7/08 (2006.01);
U.S. Cl.
CPC ...
C07C 203/04 (2013.01); A61K 31/215 (2013.01); A61K 31/235 (2013.01); A61K 31/24 (2013.01); A61K 31/621 (2013.01); C07C 69/75 (2013.01); C07C 69/76 (2013.01); C07C 69/78 (2013.01); C07C 69/86 (2013.01); C07C 247/10 (2013.01); C07C 309/76 (2013.01); C07F 7/081 (2013.01); C07F 7/1804 (2013.01); C07C 2601/14 (2017.05);
Abstract
Compounds and pharmaceutically acceptable salts of the compounds are useful in the treatment of neoplastic diseases or proliferative disorders. The compounds are formulated into pharmaceutical compositions, which can be used in methods of treating neoplastic diseases or proliferative disorders The compounds are useful to treat cancers such as prostate, pancreatic, lung, skin, breast, bladder, colon, and blood cancers. The compounds are represented by the following formula: